Aptalis Pharmaceutical Technologies
Aptalis Pharmaceutical Technologies specialises in product development that leverages our proprietary pharmaceutical technologies including Customised Drug Release, Bioavailability Enhancement, and Tastemasking for ODTs and other dosage forms. In collaboration with our partners, we utilise these technologies to develop novel prescription and OTC products that are designed to have advantages over existing products and address unmet medical needs. We have a multinational infrastructure with integrated R&D and manufacturing facilities in the U.S. and Europe, allowing us to offer global solutions to companies worldwide. We are proud of our successful quality inspection rates across our multiple facilities, which are audited annually by the various regulatory bodies.
Our capabilities include formulation through to scale-up, thereby enabling commercial-scale manufacturing of the products we develop for our partners, in addition to securing IP protection for new commercial entities created from the use of our proprietary technologies.
We also offer licensing opportunities of existing prescription and OTC products across a range of therapeutic categories. These therapeutic categories include but are not limited to: gastrointestinal, cardiovascular, pain, nutrition, respiratory and CNS indications. These products are designed to meet regulatory requirements for approval in a number of markets around the world.
Visit us at
www.AptalisPharmaTech.com to view our current product portfolio available for out-licensing and learn more about our full service co-development capabilities using our technologies.
